ESMO 2023 INDUSTRY SATELLITE SYMPOSIUM, Personalized Medicine for Nonmelanoma Skin Cancers
OVERVIEW
Join us for a live, interactive, 90-minute symposium focused on the use of immunotherapy for the treatment of nonmelanoma skin cancers, specifically cutaneous squamous cell carcinoma (CSCC) and basal cell carcinoma (BCC). Expert faculty will discuss the rationale for the use of immunotherapy in CSCC and BCC, recent clinical trial data, as well as guidelines and recommendations for incorporating immunotherapy for these skin cancers into clinical practice. Patient case vignettes will be used to emphasize the importance of the patient voice in making clinical decisions. Participants will be given the opportunity to answer polling questions throughout the program that will help them strategize considerations for treating and managing patients with CSCC and BCC as well as emphasizing the importance of the role of the multidisciplinary team to optimize care for patients.
IMPORTANT INFO
This CME symposium will be offered both in-person and virtually. Please note: you will need to be a registered attendee of ESMO 2023 in order to participate.